|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1The Pulmonary Unit and the Kathy and Lee Graub Cystic Fibrosis Center, Schneider Children's Medical Center of Israel, Petah Tikva, Israel 2The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel 3National Laboratory Center for Interstitial Lung Diseases, Institute for Pulmonary and Allergic Diseases, Sourasky Medical Center, Tel Aviv, Israel
hblau{at}post.tau.ac.il
Abstract
Background: Chronic inflammation and infection in cystic fibrosis (CF) and other lung diseases begin early, making non-invasive diagnostic techniques vital. As induced sputum (IS) is useful in older patients, we investigated its adaptation to young non-expectorating children.
Methods: Following 4.5% saline inhalation, sputum was collected by naso- or oropharyngeal suction for culture and inflammatory markers, with paired preceding oropharyngeal cough swabs (OCS) in a subgroup. Forty-eight IS procedures (46 successful) from 20 CF children, median age 3y, were compared with 8 specimens from 8 non-CF pulmonary patients, median age 4.5y.
Results: The procedure was safe, SaO2 remaining
96%. In CF, 14/46 (30%) cultured P. aeruginosa whereas 19/46 (41%) had no growth. In non-CF, 7/8 cultured bacteria, none P. aeruginosa. Comparing 29 paired IS and OCS: 11 versus 5 cultured P. aeruginosa (not significant) whereas 12 versus 21 had no growth (p=0.02). A correlation was found between independent inflammatory markers neutrophil elastase (NE) and both IL-8 (r=0.85, p< 0.001) and % neutrophils (r=0.35, p<0.05), confirming validity of IS in evaluating early airway disease. IL-8 also increased with age (r=0.41, p<0.05). Inflammation was similar in CF and non-CF subjects.
Conclusions: IS in the young is feasible, safe and clinically useful, and could serve as an outcome measure for new therapies.
Key Words: cystic fibrosis induced sputum infection inflammation non-expectorating
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |